Sissel Rodahl
Corporate Officer/Principal chez GENSIGHT BIOLOGICS S.A.
Postes actifs de Sissel Rodahl
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| GENSIGHT BIOLOGICS S.A. | Corporate Officer/Principal | 31/01/2022 | - |
Historique de carrière de Sissel Rodahl
Anciens postes connus de Sissel Rodahl
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| AVEXIS INC | Corporate Officer/Principal | 01/09/2018 | 01/02/2022 |
Formation de Sissel Rodahl
| University of Oslo | Graduate Degree |
| Engineering College | Undergraduate Degree |
Statistiques
Internationale
| Norvège | 3 |
| France | 2 |
| Etats-Unis | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GENSIGHT BIOLOGICS S.A. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
- Bourse
- Insiders
- Sissel Rodahl
- Expérience
